title: Pyruvate suppresses PGC1alpha expression and substrate utilization despite increased respiratory chain content in C2C12 myotubes.
abstract: Sodium pyruvate can increase mitochondrial biogenesis in C2C12 myoblasts in a peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC1alpha)-independent manner. The present study examined the effect of 72-h treatment with sodium pyruvate (5-50 mM) or sodium chloride (50 mM) as an osmotic control on the regulation of mitochondrial substrate metabolism and biogenesis in C2C12 myotubes. Pyruvate (50 mM) increased the levels of fatty acid oxidation enzymes (CD36, 61%, and beta-oxidative enzyme 3-hydroxyacyl-CoA dehydrogenase, 54%) and the expression of cytochrome-c oxidase subunit I (220%) and cytochrome c (228%), consistent with its previous described role as a promoter of mitochondrial biogenesis. However, in contrast, pyruvate treatment reduced glucose transporter 4 (42%), phosphofructokinase (57%), and PGC1alpha (72%) protein content as well as PGC1alpha (48%) and PGC1beta (122%) mRNA. The decrease in PGC1alpha was compensated for by an increase in the PGC1alpha-related coactivator (PRC; 187%). Pyruvate treatment reduced basal and insulin-stimulated glucose uptake (41% and 31%, respectively) and palmitate uptake and oxidation (24% and 31%, respectively). The addition of the pyruvate dehydrogenase activator dichloroacetate (DCA) and the TCA precursor glutamine increased PGC1alpha expression (368%) and returned PRC expression to basal. Glucose uptake increased by 4.2-fold with DCA and glutamine and palmitate uptake increased by 18%. Coupled to this adaptation was an 80% increase in oxygen consumption. The data suggest that supraphysiological doses of pyruvate decrease mitochondrial function despite limited biogenesis and that anaplerotic agents can reverse this effect.
authors.affiliation: Division of Molecular Physiology, Sir James Black Centre, College of Life Sciences, University of Dundee, Dundee, United Kingdom.
authors.forename: Andrew
authors.initials: A
authors.lastname: Philp
authors.forename: Joaquin
authors.initials: J
authors.lastname: Perez-Schindler
authors.forename: Charlotte
authors.initials: C
authors.lastname: Green
authors.forename: D Lee
authors.initials: DL
authors.lastname: Hamilton
authors.forename: Keith
authors.initials: K
authors.lastname: Baar
mesh_terms: D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D002952:Citric Acid Cycle / Q000187:drug effects / Q000502:physiology; D015536:Down-Regulation / Q000187:drug effects / Q000502:physiology*; D004579:Electron Transport / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D018485:Muscle Fibers, Skeletal / Q000187:drug effects / Q000378:metabolism*; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; D019289:Pyruvic Acid / Q000494:pharmacology*; D013379:Substrate Specificity / Q000187:drug effects / Q000502:physiology; D015534:Trans-Activators / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D014157:Transcription Factors; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology*
chemical_list: D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; C485290:Ppargc1a protein, mouse; D015534:Trans-Activators; D014157:Transcription Factors; D019289:Pyruvic Acid
references.citation: Nature. 2008 Jul 24;454(7203):463-9
references.pmid: 18650917
references.citation: J Physiol. 2003 Feb 1;546(Pt 3):851-8
references.pmid: 12563009
references.citation: Biochem J. 2010 Jan 27;426(1):109-18
references.pmid: 19958286
references.citation: J Biol Chem. 2007 May 25;282(21):15439-50
references.pmid: 17416903
references.citation: Biochem Biophys Res Commun. 2009 Jan 23;378(4):836-41
references.pmid: 19071085
references.citation: Diabetes Metab. 2008 Feb;34(1):82-5
references.pmid: 18063403
references.citation: J Biol Chem. 2009 Jan 23;284(4):2307-19
references.pmid: 19036724
references.citation: Nature. 2002 Aug 15;418(6899):797-801
references.pmid: 12181572
references.citation: Nat Genet. 2003 Jul;34(3):267-73
references.pmid: 12808457
references.citation: Physiol Rev. 2008 Apr;88(2):611-38
references.pmid: 18391175
references.citation: Proc Nutr Soc. 2004 May;63(2):269-73
references.pmid: 15294042
references.citation: FASEB J. 2007 Aug;21(10):2602-12
references.pmid: 17395833
references.citation: J Appl Physiol (1985). 2008 Mar;104(3):708-15
references.pmid: 18079266
references.citation: Mol Cell Biol. 2006 Oct;26(20):7409-19
references.pmid: 16908542
references.citation: J Biol Chem. 2005 Sep 30;280(39):33588-98
references.pmid: 16079133
references.citation: J Appl Physiol (1985). 2008 May;104(5):1304-12
references.pmid: 18239076
references.citation: FASEB J. 2002 Dec;16(14):1879-86
references.pmid: 12468452
references.citation: Cell Metab. 2008 Jan;7(1):5-6
references.pmid: 18177719
references.citation: Dev Cell. 2008 May;14(5):661-73
references.pmid: 18477450
references.citation: FEBS Lett. 2007 Oct 2;581(24):4743-8
references.pmid: 17869249
references.citation: Mol Cell Biol. 2001 Jun;21(11):3738-49
references.pmid: 11340167
references.citation: Diabetes. 2003 Apr;52(4):926-8
references.pmid: 12663462
references.citation: J Biol Chem. 2008 Aug 15;283(33):22464-72
references.pmid: 18579525
references.citation: J Biol Chem. 2007 Oct 12;282(41):30014-21
references.pmid: 17702743
references.citation: Diabetes. 2006 Oct;55(10):2779-87
references.pmid: 17003343
references.citation: J Biol Chem. 2008 May 2;283(18):12102-11
references.pmid: 18343819
references.citation: Am J Med. 2006 May;119(5 Suppl 1):S10-6
references.pmid: 16563942
references.citation: Am J Physiol Cell Physiol. 2007 May;292(5):C1599-605
references.pmid: 17182725
references.citation: Am J Clin Nutr. 2009 Jan;89(1):463S-6S
references.pmid: 19056574
references.citation: Am J Physiol Cell Physiol. 2006 Apr;290(4):C1119-27
references.pmid: 16531567
references.citation: Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E463-74
references.pmid: 18073319